BMRN BioMarin Pharmaceutical Inc

- Bank of America Merrill Lynch 2016 Health Care Conference on May 11 in Las Vegas  - Goldman Sachs 37th Annual Global Healthcare Conference on June 9 in Ranchos Palos Verdes, California

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in the Bank of America Merrill Lynch 2016 Health Care Conference on May 11, 2016 at 10:00am PT/1:00pm ET, in Las Vegas and the Goldman Sachs 37th Annual Global Healthcare Conference on June 9, 2016 at 10:00am PT/1:00pm ET, in Ranchos Palos Verdes, California.  To access the live webcasts, please visit the investor section of the BioMarin website, www.BMRN.com. A replay will also be archived on the site for at least one week following the event.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of five commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:

Investors
Traci McCarty
BioMarin Pharmaceutical Inc.
(415) 455-7558

Media
Debra Charlesworth
BioMarin Pharmaceutical Inc.
(415) 455-7451